addition for open access, is not supported. A complete description can be found at: https://www.coalition-s.org/principles-andimplementation.
The initiative was born from the cooperation between the heads of the participating Research Funding Organizations: Marc Schiltz, the President of Science Europe; and Robert-Jan Smits, the Open Access Envoy of the European Commission. It also drew on significant input from the Scientific Council of the ERC. cOAlition S currently comprises 13 national research funding organizations and 4 charitable foundations who have agreed to implement the 10 principles of Plan S in a coordinated way, together with the European Commission and the ERC. Other research funders from across the world are expected to join in the near future (see the updated list at: https://www.coalition-s. org/funders/).
There has been some anxiety among researchers and publishers, as is the case with any change. The open access principle seems to be widely supported, but there is fear that the introduction of strict rules will limit researchers and restrict the choice of journals where they can publish. Young researchers pointed out that they need to be able to publish in a top journal to accelerate their career and this may become more difficult with additional rules. This is indeed a potential problem, but if all funding agencies adopt the Plan S principles, all important journals will need to adapt and offer full open access for a reasonable cost. That is at least what is hoped by the consortium and by the researchers worldwide who support this initiative.
EHA has been supporting many of these principles for more than 20 years. In the past, EHA and the Ferrara Storti Foundation published Haematologica, an open access journal with low publication fees, which is completely in line with the spirit behind Plan S. Since 2017, EHA is publishing HemaSphere, its own open access journal. There was universal agreement among the EHA board members that this new journal had to be open access and offer low publication fees. Authors publishing their work in HemaSphere retain the copyright of their work, removing the restrictions they would otherwise later face when wishing to use their own work for education, research, or sharing. EHA invests in its journal by offering open access publication against low fees, not only for its members, but also for the entire international hematology community.
What will change for you as an author?
It is likely that most, if not all, funding agencies will adopt Plan S in the future and you will be obliged to publish your work in compliant open access journals or platforms. This may start as early as 2021 and will most likely have a (short) transition period to allow non-open access journals to change their business models. There is indeed a need for such a transition period so that journals and societies who want to change their models can find sufficient time to make this change.
If you publish your work in HemaSphere, there will be no problem at all. HemaSphere not only completely adheres to the principles of Plan S, but is also built around these principles! 1 HemaSphere is non-profit, fully open access, allows authors to retain their copyrights, uses the CC-BY (creative commons) licenses, and charges a very low article processing contribution (APC). This is completely in line with EHA's aim to promote excellence in patient care, research, and education in hematology. Keep calm and publish in open-access journals such as HemaSphere!
